Skip to main content

Table 1 Comparisons of clinical data of three groups of STEMI patients

From: Favorable factors for the survival of ST-segment elevation myocardial infarction patients with medium- and high-risk thrombolysis in myocardial infarction scores

 

Low-risk group (n = 195)

Medium-risk group (n = 165)

High-risk group (n = 73)

Pa

Pb

General data

 Age (Year)

53.00 (31.00, 77.00)

66.00 (37.00, 88.00)

73.00 (28.00, 90.00)

 < 0.0001

 < 0.0001

Gender

 Male (n, %)

175 (89.74%)

132 (80.00%)

46 (63.01%)

0.0093

 < 0.0001

 Female (n, %)

20 (10.26%)

33 (20.00%)

27 (36.99%)

Weight (kg)

70.00 (47.00, 105.0)

62.00 (32.00, 91.00)

62.00 (40.00, 86.00)

 < 0.0001

 < 0.0001

Emergency PCI (n, %)

116 (59.49%)

74 (44.85%)

23 (31.51%)

0.0056

 < 0.0001

SBP (mm Hg)

128.0 (100.0, 225.0)

125.0 (82.00, 199.0)

107.0 (60.00, 176.0)

0.2980

 < 0.0001

DBP (mm Hg)

81.00 (59.00, 133.0)

76.00 (47.00, 123.0)

67.00 (46.00, 125.0)

0.0033

 < 0.0001

Heart rate (beats/min)

77.00 (45.00, 106.0)

78.00 (39.00, 143.0)

85.00 (40.00, 151.0)

0.4267

 < 0.0001

Time of onset (h)

7.00 (0.50, 480.0)

10.00 (0.50, 720.0)

23.00 (1.00, 720.0)

0.0304

 < 0.0001

Myocardial infarction site

   

0.0063

 < 0.0001

 Anterior wall (n)

80

93

53

  

 Inferior wall (n)

111

71

19

  

 Lateral wall (n)

4

0

1

  

 Posterior wall (n)

0

1

0

  

Blood routine

 WBC (× 109/L)

10.89 (4.27, 19.99)

10.17 (3.74, 22.04)

8.75 (1.37, 28.09)

0.1745

0.0014

 LYM (× 109/L)

1.65 (0.50, 6.71)

1.48 (0.39,4.38)

1.42 (00.32, 3.88)

0.0581

0.0043

 BASR (%)

0.30 (0.00, 1.30)

0.30 (0.00, 1.60)

0.40 (0.10, 17.96)

0.4039

0.0450

 Hb (g/L)

148.0 (92.00, 203.0)

140.0 (52.00, 176.0)

130.0 (60.00, 178.0)

 < 0.0001

 < 0.0001

 ERY (× 1012/L)

4.83 (2.86, 6.37)

4.56 (2.30, 5.76)

4.34 (2.19, 5.67)

 < 0.0001

 < 0.0001

 HCT (%)

44.70 (29.10, 58.50)

42.40 (16.50, 52.80)

39.90 (19.50, 52.60)

 < 0.0001

 < 0.0001

 MCV (fL)

91.70 (77.50, 104.0)

92.90 (62.50, 107.7)

93.40 (76.40, 105.2)

0.0643

0.0079

 MCHC (g/L)

334.10 ± 10.94

330.70 ± 11.32

325.40 ± 11.27

0.0069

 < 0.0001

 RDW (SD, fL)

43.70 (36.50, 58.50)

44.80 (36.90, 62.80)

46.50 (35.40, 58.90)

0.0202

 < 0.0001

 CV (%)

13.00 (10.80, 17.80)

13.20 (11.70, 17.80)

13.50 (11.80, 17.20)

0.1118

0.0023

Biochemical indicators

 AST (U/L)

82 (0, 690)

84 (0, 1299)

47 (0, 511)

 > 0.9999

0.0312

 SCr (μmol/L)

77 (44, 222)

80 (41, 161)

90 (47, 391)

0.7265

 < 0.0001

 ALB (g/L)

40.90 (27.40, 54.30)

39.90 (25.00, 47.30)

37.70 (26.40, 46.70)

0.0004

 < 0.0001

 GLB (g/L)

23.21 ± 3.439

24.69 ± 4.075

25.51 ± 4.472

0.0007

 < 0.0001

 A/G

1.77 (1.09, 2.86)

1.59 (0.83, 2.48)

1.43 (0.88, 2.48)

 < 0.0001

 < 0.0001

 TC (mmo1/L)

4.32 (2.38, 8.64)

4.07 (2.20, 7.58)

4.00 (1.93, 8.44)

0.0226

0.0158

 TG (mmo1/L)

1.63 (0.35, 12.20)

1.33 (0.34, 6.20)

1.27 (0.43, 7.80)

0.0022

0.0085

 LDL (mmo1/L)

2.90 (1.05, 6.35)

2.59 (0.95, 6.13)

2.51 (0.78, 6.75)

0.0062

0.0169

 Blood urea nitrogen (mmo1/L)

4.70 (1.40, 14.76)

5.16 (1.40, 18.00)

6.60 (2.60, 25.96)

0.0273

 < 0.0001

 K

3.92 (2.67, 7.90)

4.02 (2.68, 4.99)

4.04 (3.15, 5.77)

0.6244

0.0407

Coagulation indicators

 PT (s)

11.6 (9.6, 21.4)

11.8 (9.9, 20.1)

12.1 (10.7, 20.4)

0.0372

0.0003

 PtA (%)

94.0 (36.0, 138.0)

90.0 (40.0, 135.0)

85.0 (37.0, 117.0)

0.0099

0.0003

  1. Note: SBP Systolic blood pressure, DBP Diastolic blood pressure, WBC White blood cell, LYM Lymphocyte, BASR Basophil ratio, Hb Hemoglobin, ERY Erythrocyte, HCT Hematocrit, MCV Mean corpuscular volume, MCHC Mean corpuscular hemoglobin concentration, RDW Red blood cell distribution width, CV Coefficient of variation, AST Aspartate aminotransferase, SCr Serum creatinine, ALB Albumin, GLB Globulin, TC Total cholesterol, TG Triglyceride, LDL Low density lipoprotein, K Potassium, PT Prothrombin time, PtA Prothrombin activity. The Shapiro–Wilk test was used to test the normal distribution, and the measurement data of the normal distribution were expressed as the mean ± SD, and analyzed by one-way ANOVA, followed by Tukey’s multiple comparisons test. The non-normally distributed measurement data were represented by quartiles [median value (minimum value, maximum value)], and analyzed by the Kruskal–Wallis H test. Categorical variables were expressed using the number of cases or percentages, and analyzed by Chi-square test. Pa: the medium-risk group vs. the low-risk group; Pb: the high-risk group vs. the low-risk group. When TnI > 25 ng/mL, the patient had severe myocardial injury